학술논문

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
Document Type
Article
Source
In: The Lancet. (The Lancet, 7 October 2023, 402(10409):1272-1281)
Subject
Language
English
ISSN
1474547X
01406736